Traumatic Brain Injury and Alzheimer's Disease/Related Dementias Caregiver Support Intervention
TACSI
Designing and Evaluating a Comprehensive Support Program for Families Caring for Relatives Living With TBI-AD/ADRD
2 other identifiers
interventional
95
1 country
1
Brief Summary
The TBI-AD/ADRD Caregiver Support Intervention (TACSI) incorporates psychosocial and psychoeducational approaches with the objective of: a) identifying stressors associated with caregiving for family members who have the dual diagnosis of traumatic brain injury and dementia; and b) supporting caregivers in developing more effective coping and communication strategies as well as enhanced caregiving self-efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 15, 2022
CompletedFirst Posted
Study publicly available on registry
July 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2025
CompletedDecember 22, 2025
December 1, 2025
3 years
July 15, 2022
December 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Caregiver primary subjective stress- Phase 1
Change in score from baseline to Module 6
change in score from baseline to 3 months
Caregiver primary subjective stress- Phase 2, 3mo
Change in score from baseline to Module 6
change in score from baseline to 3 months
Caregiver primary subjective stress- Phase 2, 6mo
Change in score from baseline to Module 6
change in score from baseline to 6 months
Study Arms (2)
TACSI
EXPERIMENTALUsual care control group
NO INTERVENTIONThe usual care control group would have continued receipt of standard services at either the Mayo Clinic or the MVAHCS. In addition, staff will offer participants the opportunity to request supportive/educational resources as needed after randomization.
Interventions
The TBI-AD/ADRD Caregiver Support Intervention (TACSI) incorporates psychosocial and psychoeducational approaches with the objective of: a) identifying stressors associated with caregiving for family members who have the dual diagnosis of traumatic brain injury and dementia; and b) supporting caregivers in developing more effective coping and communication strategies as well as enhanced caregiving self-efficacy. This intervention offers individual and family coaching and knowledge and skills to help manage stress and reduce caregiver burden.
Eligibility Criteria
You may qualify if:
- the care recipient has a physician diagnosis of TBI and AD/ADRD (i.e., those with a diagnosis of both TBI and progressive cognitive decline)
- the caregiver self-identifies as someone who provides the most help/is most responsible for the person with TBI-AD/ADRD because of their cognitive impairments (or shares the role equally with another caregiver)
- the caregiver indicates a willingness to participate in the TACSI evaluation
- the caregiver is English speaking
- the caregiver is 21 years of age or older
- the caregiver is not currently participating in any other type of service that provides one-to-one psychosocial consultation or caregiver coaching (peer mentorship/support group participation/general counseling not specific to caregiving is not a deterrent to enrollment) at the discretion of the UMN research team
- the caregiver resides in the US.
You may not qualify if:
- caregivers who have a new or worsening mental health condition and are not receiving ongoing treatment. When applicable, if caregivers have not remained on a stable psychotropic medications dosage, such as antidepressants, anxiolytics or anti-psychotics, for the prior three months they will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Minnesotalead
- Mayo Cliniccollaborator
- Congressionally Directed Medical Research Programscollaborator
- United States Department of Defensecollaborator
- Minneapolis Veterans Affairs Medical Centercollaborator
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2022
First Posted
July 19, 2022
Study Start
July 1, 2022
Primary Completion
June 28, 2025
Study Completion
June 28, 2025
Last Updated
December 22, 2025
Record last verified: 2025-12